AMLX
Amylyx Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$13.99
-0.39 ▼ -2.71%
🌙 3월 13일 4:50 PM ET (한국 3/14 05:50)
$13.71
-0.28 ▼ -2.00%
| Index | RUT | P/E | - | EPS (ttm) | -1.55 | Insider Own | 15.99% | Shs Outstand | 0.11B | Perf Week | 1.01% |
| Market Cap | 1.55B | Forward P/E | - | EPS next Y | 7.2% | Insider Trans | -2.78% | Shs Float | 0.09B | Perf Month | -2.51% |
| Enterprise Value | 1.24B | PEG | - | EPS next Q | -0.33 | Inst Own | 95.89% | Short Float | 15.61% | Perf Quarter | 5.74% |
| Income | -0.14B | P/S | - | EPS this Y | 12.03% | Inst Trans | 1.68% | Short Ratio | 10.02 | Perf Half Y | 18.16% |
| Sales | 0.00B | P/B | 5.04 | EPS next 5Y | 26.71% | ROA | -54.85% | Short Interest | 14.50M | Perf YTD | 15.81% |
| Book/sh | 2.78 | P/C | 4.88 | EPS past 3/5Y | 19.94% -15.37% | ROE | -61.59% | 52W High | -20.01% ($17.49) | Perf Year | 281.2% |
| Cash/sh | 2.87 | P/FCF | - | Sales past 3/5Y | - | ROIC | -46.7% | 52W Low | 349.84% ($3.11) | Perf 3Y | -55.12% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 64.98% | Gross Margin | - | Volatility(W/M) | 7.69% 6.84% | Perf 5Y | - |
| Dividend TTM | - | EV/Sales | - | Sales Y/Y TTM | -100% | Oper. Margin | - | ATR (14) | 1.03 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 14.27 | EPS Q/Q | 45.12% | Profit Margin | - | RSI (14) | 46.77 | Recom | 1.25 |
| Dividend Gr. 3/5Y | - | Current Ratio | 14.27 | Sales Q/Q | 100% | SMA20 | -3.11% ($14.44) | Beta | -0.26 | Target Price | $22.3 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 3000000 | SMA50 | -0.79% ($14.1) | Rel Volume | 0.52 | Prev Close | $14.38 |
| Employees | 136 | LT Debt/Eq | 0.02 | EPS/Sales Surpr. | 14.7% 100% | SMA200 | 22.15% ($11.45) | Avg Volume(3M) | 1.45M | Price | $13.99 |
| IPO | 2022/1/7 | Option/Short | Yes/Yes | Trades | 8303 | Volume | 759,104 | Change | -2.71% |
뉴스 로딩 중...